Skip to main content

Europe

Insurance Insight Update - 11 November

Insurance Insight’s weekly update is live with an article the biggest man-made disaster in Cypriot history; and a blog on why more education is needed in the Middle East.

EIOPA launches public consultation on Solvency II

In order to facilitate the preparatory work of insurance and reinsurance undertakings for Solvency II, the European Insurance and Occupational Pensions Authority has opened a public consultation with regards to supervisory reporting & public disclosure…

BWise and LiBi to join forces in Israel

BWise, governance, risk and compliancemanagement software solutions specialist, has entered into a partnership agreement with business intelligence firm LiBi Software Technology in Israel.

Natcats and the insurance sector

The European Union is currently consulting on natural catastrophes. Vic Wyman reports on the part the insurance industry has to play.

Q&A: Jorge Luzzi

Jorge Luzzi, president of Ferma and corporate risk management director at Pirelli & C SpA spoke to Francesca Nyman about what risk managers want from insurers, the current economic climate and what he aim to achieve in his two year presidency.

The challenge of life sciences

Mid-sized life sciences firms offer an attractive opportunity for insurers in Europe with many entering the market. Yet as Francesca Nyman reports litigation and legislation make this a challenging market too.

Insurance Insight November

Insurance Insight November is now live with an article on The European Commission’s consultation on natural catastrophes; a look the challenges the life sciences sector is facing; and an interview with Jorge Luzzi, president of Ferma.

Reaction to proposed ELD extension

The CEA claims the proposed extension to the Environmental Liability Directive will be damaging for European insurers. Francesca Nyman asks the market for its initial reaction to the proposal.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here